ICU (SeaStar Medical Holding) Change In Receivables : $0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is SeaStar Medical Holding Change In Receivables?

SeaStar Medical Holding's change in receivables for the quarter that ended in Sep. 2024 was $0.00 Mil. It means SeaStar Medical Holding's Accounts Receivable stayed the same from Jun. 2024 to Sep. 2024 .

SeaStar Medical Holding's change in receivables for the fiscal year that ended in Dec. 2023 was $0.01 Mil. It means SeaStar Medical Holding's Accounts Receivable declined by $0.01 Mil from Dec. 2022 to Dec. 2023 .

SeaStar Medical Holding's Accounts Receivable for the quarter that ended in Sep. 2024 was $0.07 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. SeaStar Medical Holding's Days Sales Outstanding for the three months ended in Sep. 2024 was 91.25.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. SeaStar Medical Holding's liquidation value for the three months ended in Sep. 2024 was $-4.51 Mil.

SeaStar Medical Holding Change In Receivables Historical Data

The historical data trend for SeaStar Medical Holding's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SeaStar Medical Holding Change In Receivables Chart

SeaStar Medical Holding Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Change In Receivables

0.01

SeaStar Medical Holding Quarterly Data
	Dec20	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Receivables	Get a 7-Day Free Trial										-	-	-	-	-

SeaStar Medical Holding Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

SeaStar Medical Holding (NAS:ICU) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

SeaStar Medical Holding's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.068	/	0.068	*	91
=	91.25

2. In Ben Graham's calculation of liquidation value, SeaStar Medical Holding's accounts receivable are only considered to be worth 75% of book value:

SeaStar Medical Holding's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2.082	-	6.638	+	0.75 * 0.068	+	0.5 * 0
=	-4.51

SeaStar Medical Holding Change In Receivables Related Terms

Thank you for viewing the detailed overview of SeaStar Medical Holding's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

SeaStar Medical Holding Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SeaStar Medical Holding Corp (NAS:ICU) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

3513 Brighton Boulevard, Suite 410, Denver, CO, USA, 80216

Website

https://www.seastarmedical.com

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Executives

Kevin Chung	officer: Chief Medical Officer	C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Heel Kenneth Van	director	C/O PFENEX INC., 10790 ROSELLE STREET, SAN DIEGO CA 92121
Richard D. Russell	director	3201 W BAY VISTA AVE, TAMPA FL 33611
Bruce M. Rodgers	director	302 KNIGHTS RUN AVE., STE. 1000, TAMPA FL 33602
Andres Lobo	director	C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Caryl Baron	officer: See Remarks	C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Eric Schlorff	director, officer: Chief Executive Officer	C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Rick Barnett	director	C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Allan Collins	director	C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Dow Employees' Pension Plan Trust	10 percent owner	2211 H.H. DOW WAY, SSC BUILDING, MIDLAND MI 48674
Union Carbide Employees' Pension Plan Trust	10 percent owner	2211 H.H. DOW WAY, SSC BUILDING, MIDLAND MI 48674
Martin A Traber	director	100 N TAMPA STREET, SUITE 2700, TAMPA FL 33602
Lm Funding America, Inc.	10 percent owner	1200 WEST PLATT STREET, SUITE 100, TAMPA FL 33606
Craig E Burson	director	400 N. PARK AVENUE, UNIT 10B, BRECKENRIDGE CO 80424
Bruce H Bennett	director	3929 ARLINGTON DRIVE, PALM HARBOR FL 34685